Kiran Nistala - 27 Feb 2025 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Medical Officer and Head of Development
Signature
/s/ Kiran Nistala
Issuer symbol
ZURA
Transactions as of
27 Feb 2025
Net transactions value
$0
Form type
4
Filing time
03 Mar 2025, 17:02:54 UTC
Previous filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +341,700 $0.000000 341,700 27 Feb 2025 Class A Ordinary Shares 341,700 $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Chief Medical Officer and Head of Development